A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]
Clinical trial NCT02297438 · COMPLETED
Trial details
- NCT number
- NCT02297438
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-23
- Primary completion
- 2020-08-31
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.